Literature DB >> 25001210

Molecular cloning and expression of high GC-rich novel tumor suppressor gene HIC-1.

Sanjay Kumar1.   

Abstract

Hypermethylated in Cancer-1 (HIC-1) is a novel tumor suppressor plays crucial role in tumor formation through loss of function by hypermethylation. HIC-1 is known as transcriptional factor whereas little known about its structure and function. Requirement felt to clone and express full coding protein and reveal various domains and binding pattern onto promoters conducting biophysical studies which lack in current scenario. Production of sufficient amounts of protein is frequent bottleneck in structural biology. Cloning full-length HIC-1 with >73 % GC content poses a daunting task with sequencing and expression adds more to the challenge. We describe the methodology for specific amplification, cloning, sequencing, and expression of HIC-1 in E. coli. Standardization using 1.5 U pfu polymerase in (NH4)2SO4 containing buffer gave specific amplification with 10 % DMSO and 1.5 mM MgCl2. Sequencing achieved using base analog 7-de aza dGTP (0.2 mM) or denaturant like DMSO (10 %) or betaine (1 M). Expression using strains of E. coli induced by different concentrations of IPTG (0.5-5.0 mM) for time points of 4, 8, 16, 20, and 24 h at different temperatures 25, 30, and 37 °C. Full-length clone successfully expressed in BL21-Codon Plus-RP using 1 mM concentration of IPTG for 8 h at 37 °C gave prominent band of 74 kDa.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25001210     DOI: 10.1007/s12033-014-9783-8

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  20 in total

1.  GC-rich template amplification by inverse PCR. DNA polymerase and solvent effects.

Authors:  Alain Moreau; Da Shen Wang; Steve Forget; Colette Duez; Jean Dusart
Journal:  Methods Mol Biol       Date:  2002

2.  Formamide can dramatically improve the specificity of PCR.

Authors:  G Sarkar; S Kapelner; S S Sommer
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

3.  Analysis and suppression of DNA polymerase pauses associated with a trinucleotide consensus.

Authors:  D S Mytelka; M J Chamberlin
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

4.  Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.

Authors:  S Deltour; C Guerardel; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  PCR-direct sequencing of a GC-rich region by inclusion of 10% DMSO: application to mouse c-jun.

Authors:  Y Sun; G Hegamyer; N H Colburn
Journal:  Biotechniques       Date:  1993-09       Impact factor: 1.993

6.  Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53.

Authors:  C Guerardel; S Deltour; S Pinte; D Monte; A Begue; A K Godwin; D Leprince
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

7.  PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies.

Authors:  G L Mutter; K A Boynton
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

8.  Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.

Authors:  Brian R Rood; Huizhen Zhang; David M Weitman; Philip H Cogen
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  DNA hypermethylation is associated with 17p allelic loss in neural tumors.

Authors:  M Makos; B D Nelkin; V R Chazin; W K Cavenee; G M Brodeur; S B Baylin
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

10.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

View more
  2 in total

1.  Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells.

Authors:  Fan Feng; Xiaolan Zhu; Chunyan Wang; Liang Chen; Weiping Cao; Yueqin Liu; Qi Chen; Wenlin Xu
Journal:  Cancer Cell Int       Date:  2018-09-04       Impact factor: 5.722

2.  Simplified plasmid cloning with a universal MCS design and bacterial in vivo assembly.

Authors:  Fan Chen; Yi-Ya Li; Yan-Li Yu; Jie Dai; Jin-Ling Huang; Jie Lin
Journal:  BMC Biotechnol       Date:  2021-03-15       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.